PROCEPT BioRobotics Corp Files Definitive Proxy Statement

TL;DR

<b>PROCEPT BioRobotics Corp has filed its Definitive Proxy Statement for the period ending April 22, 2024.</b>

AI Summary

PROCEPT BioRobotics Corp (PRCT) filed a Proxy Statement (DEF 14A) with the SEC on April 22, 2024. PROCEPT BioRobotics Corp filed a Definitive Proxy Statement (DEF 14A) on April 22, 2024. The filing covers the period ending April 22, 2024. The company's fiscal year ends on December 31. PROCEPT BioRobotics Corp is incorporated in Delaware. The company's principal business address is 150 Baytech Drive, San Jose, CA 95134.

Why It Matters

For investors and stakeholders tracking PROCEPT BioRobotics Corp, this filing contains several important signals. This filing is a standard procedural document required for publicly traded companies to solicit proxies from shareholders for annual meetings. It provides detailed information on corporate governance, executive compensation, and matters to be voted on by shareholders, which is crucial for investor understanding and participation.

Risk Assessment

Risk Level: low — PROCEPT BioRobotics Corp shows low risk based on this filing. The filing is a routine DEF 14A, indicating no immediate material events or significant changes are being disclosed beyond standard corporate governance procedures.

Analyst Insight

Review the proxy statement for details on executive compensation, board nominations, and any shareholder proposals to understand management's strategy and potential impacts on shareholder value.

Key Numbers

• 2024-04-22 — Filing Date (DEF 14A)
• 2024-04-22 — Period of Report (DEF 14A)
• 1231 — Fiscal Year End (Company Data)
• 26 — Public Document Count (DEF 14A)

Key Players & Entities

• PROCEPT BioRobotics Corp (company) — Filer
• 2024-04-22 (date) — Filing Date
• 150 Baytech Drive (address) — Business Address
• San Jose (location) — Business Address City
• CA (location) — Business Address State
• 95134 (postal_code) — Business Address Zip
• DE (location) — State of Incorporation
• 1934 Act (regulation) — SEC Act

FAQ

Industry Context

PROCEPT BioRobotics Corp operates in the surgical and medical instruments & apparatus industry, focusing on robotic solutions for surgical procedures.

Regulatory Implications

The filing is made under the Securities Exchange Act of 1934, requiring public companies to provide regular disclosures to shareholders and the SEC.

What Investors Should Do

1. Review executive compensation details to assess alignment with company performance.
2. Examine any shareholder proposals for potential impact on company strategy.
3. Note the date of the annual meeting (if specified) for proxy voting deadlines.

Key Dates

• 2024-04-22: Filing of DEF 14A — Indicates the company is proceeding with standard corporate actions and disclosures.

Year-Over-Year Comparison

This is a DEF 14A filing, which is a routine disclosure. No specific comparative data from a previous filing is immediately apparent in this header information.

Filing Documents

• prct-20240422.htm (DEF 14A) — 754KB
• prct-20240422_g1.jpg (GRAPHIC) — 4KB
• prct-20240422_g10.jpg (GRAPHIC) — 134KB
• prct-20240422_g11.jpg (GRAPHIC) — 142KB
• prct-20240422_g2.jpg (GRAPHIC) — 13KB
• prct-20240422_g3.jpg (GRAPHIC) — 1KB
• prct-20240422_g4.jpg (GRAPHIC) — 57KB
• prct-20240422_g5.jpg (GRAPHIC) — 28KB
• prct-20240422_g6.jpg (GRAPHIC) — 28KB
• prct-20240422_g7.jpg (GRAPHIC) — 63KB
• prct-20240422_g8.jpg (GRAPHIC) — 61KB
• prct-20240422_g9.jpg (GRAPHIC) — 64KB
• 0001628280-24-017167.txt (&nbsp;) — 2753KB
• prct-20240422.xsd (EX-101.SCH) — 3KB
• prct-20240422_def.xml (EX-101.DEF) — 4KB
• prct-20240422_lab.xml (EX-101.LAB) — 5KB
• prct-20240422_pre.xml (EX-101.PRE) — 3KB
• prct-20240422_htm.xml (XML) — 97KB

Executive Compensation

Executive Compensation 23 Pay Versus Performance 37 Certain Relationships and Related Party Transactions 38 Householding of Proxy Materials 41 Other Matters 42 i PROCEPT BioRobotics Corporation 150 Baytech Drive San Jose, CA 94065 PROXY STATEMENT FOR THE 2024 ANNUAL MEETING OF STOCKHOLDERS TO BE HELD JUNE 4, 2024 QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND VOTING Why did I receive a one-page notice in the mail regarding the internet availability of proxy materials instead of a full set of proxy materials? Pursuant to "Notice and Access" rules adopted by the Securities and Exchange Commission (the "SEC"), we have elected to provide access to our proxy materials over the internet. Accordingly, we are sending an Important Notice Regarding the Availability of Proxy Materials (the "Notice") to our stockholders of record. Brokers and other nominees will be sending a similar Notice to all beneficial owners of stock who hold their shares through such broker or nominee. All record and beneficial stockholders will have the ability to access the proxy materials on the website referred to in the Notice free of charge or request to receive a printed set of the proxy materials for the Annual Meeting. Instructions on how to access the proxy materials over the internet or to request a printed copy may be found in the Notice. On or about April 22, 2024, we intend to make this proxy statement available on the internet and to commence mailing of the Notice to all stockholders entitled to vote at the Annual Meeting. We intend to mail this proxy statement, together with a proxy card, to those stockholders entitled to vote at the Annual Meeting who properly request paper copies of such materials, within three business days of such request. Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting to be held on June 4, 2024 at 1:00 p.m. (Eastern Time) via the internet please visit www.envisionreports/PRCT for more de

View Full Filing

View this DEF 14A filing on SEC EDGAR